Clinically significant obstructive sleep apnea syndrome (OSA) is defined as one of the following:
Clinically significant OSA in adults is:
An apneic-hypopneic index (AHI), respiratory distress index (RDI), or respiratory event index (REI) of greater or equal to (≥) 15, OR
An AHI, RDI, or REI greater or equal to (≥) 5 in an individual with 1 or more signs or symptoms associated with OSA (e.g., excessive daytime sleepiness, hypertension, cardiovascular heart disease, or stroke).
Clinically significant OSA in pediatric individuals is:
An AHI or RDI greater or equal to (≥) 5 OR
An AHI or RDI greater or equal to (≥) 1.5 in an individual with excessive daytime sleepiness, behavioral problems or hyperactivity
SOURCES
BlueCross BlueShield Association. Evidence Positioning System. (7:2022). Diagnosis of Obstructive Sleep Apnea (2.01.18). Retrieved September 16, 2022 from https://www.evidencepositioningsystem.com/. (20 articles and/or guidelines reviewed)
BlueCross BlueShield Association. Evidence Positioning System. (7:2022). Medical Management of Obstructive Sleep Apnea Syndrome (8.01.67). Retrieved September 16, 2022 from https://www.evidencepositioningsystem.com/. (48 articles and/or guidelines reviewed)
This document has been classified as public information.